References
- Jorde LB, Rogers AR, Bamshad M, et al. Microsatellite diversity and the demographic history of modern humans. P Natl A Sci. 1997;94:3100–3103.
- Zimmet PZ, Alberti K. Introduction: Globalization and the non-communicable disease epidemic. Obesity. 2006;14:1–3.
- Okunade AA, Murthy VN. Technology as a ‘major driver’ of health care costs: a cointegration analysis of the Newhouse conjecture. J Health Econ. 2002;21:147–159.
- Flora P. Development of welfare states in Europe and America. New York: Routledge. 2017; Available from: https://www.taylorfrancis.com/books/e/9781351304917
- Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: a red herring? Health Econ. 1999;8:485–496.
- Getzen TE. Modeling the cost of medical care for the elderly. Healthwatch. 2014;74:21–25.
- Fan VY, Savedoff WD. The health financing transition: A conceptual framework and empirical evidence. Soc Sci Med. 2014;105:112–121.
- Huidrom R, Kose A, Ohnsorge FL. 2017. How important are spillovers from major emerging markets? (English). Policy Research working paper; no. WPS 8093. Washington, DC: World Bank Group. [cited 2018 Oct 14]. Available from: http://documents.worldbank.org/curated/en/786391496863791206/How-important-are-spillovers-from-major-emerging-markets
- Jakovljevic MB. BRIC’s growing share of global health spending and their diverging pathways. Front Public Health. 2015;3:135.
- Tulchinsky T, Varavikova E. The New Public Health. Aust NZ J Publ Heal. 2015;39:22–31.
- Jakovljevic MB, Milovanovic O. Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front Public Health. 2015;3:65.
- Lorenzoni L. Public Expenditure Projections for Health and Long-Term Care for China Until 2030. OECD Health Working Papers No. 84, Paris: OECD. 2017.
- Engelgau M, Rosenhouse S, El-Saharty S, et al. The economic effect of noncommunicable diseases on households and nations: a review of existing evidence. J Health Commun. 2011;16:75–81.
- Mayer-Foulkes DA. A survey of macro damages from Non-communicable NCDs diseases: another challenge for global governance. Global Econ J. 2011;11: [cited 2018 Oct 21]. Available from: https://www.degruyter.com/view/j/gej.2011.11.1/gej.2011.11.1.1725/gej.2011.11.1.1725.xml
- Division for Sustainable Development Goals. Transforming our world: the 2030 Agenda for Sustainable Development, New York. [cited 2018 Oct 20]. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld
- Schmidt MI, Duncan BB, e Silva GA, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011;377:1949–1961.
- Bloom DE, Cafiero ET, McGovern ME, et al. The economic impact of non-communicable disease in China and India: estimates, projections, and comparisons. PGDA working paper No. 107. 2013;1–22. Available from: http://cdn1.sph.harvard.edu/wp-content/uploads/sites/1288/2013/10/PGDA_WP_107.pdf.
- Srivastava RK, Bachani D. Burden of NCDs, policies and programme for prevention and control of NCDs in India. Indian J Community Med. 2011;36:S7.
- Jakovljevic M, Potapchik E, Popovich L, et al. Evolving health expenditure landscape of the BRICS nations and projections to 2025. Health Econ. 2017;26:844–852.
- Alwan A, MacLean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376:1861–1868.
- Harmer A, Fleck F. The BRICS countries: a new force in global health? Bull WHO. 2014;92:394–395.
- BRICS Joint Statistical Publication. South Africa Government BRICS SA 2018. [cited 2018 Sep 10]. Available from: http://www.statssa.gov.za/wp-content/uploads/2018/11/BRICS-JSP-2018.pdf
- Huidrom R, Kose A, Ohnsorge FL. 2017. How important are spillovers from major emerging markets? (English). Policy Research working paper; no. WPS 8093. Washington, D.C.: World Bank Group. [cited 2018 Sep 17]. Available from: http://documents.worldbank.org/curated/en/786391496863791206/How-important-are-spillovers-from-major-emerging-markets
- Kose A. Big emerging market economies versus the G-7: Which group will drive the upswing in global growth? 2017; [cited 2018 Sep 17]. Available from: https://www.brookings.edu/blog/up-front/2017/07/14/big-emerging-market-economies-versus-the-g-7-which-group-will-drive-the-upswing-in-global-growth/
- Arredondo A, Zuñiga A, Parada I. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. Public Health. 2005;119:711–720.
- Sridhar D, Brolan CE, Durrani S, et al. Recent shifts in global governance: implications for the response to non-communicable diseases. PLoS Med. 2013;10:e1001487.
- The World Bank. The World Bank In China, Washington. 2016; [cited 2018 Sep 19]. Available from: http://www.worldbank.org/en/country/china/overview#1
- Marten R, McIntyre D, Travassos C, et al. An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS). The Lancet. 2014;384:2164–2171.
- Barceló A, Aedo C, Rajpathak S, et al. The cost of diabetes in Latin America and the Caribbean. B WHO. 2003;81:19–27.
- World Health Organization, Geneva. From Burden to “Best Buys”: Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries, 2011; [cited 2018 Sep 19]. Available from: https://www.who.int/nmh/publications/best_buys_summary.pdf?ua=1
- Allen LN, Pullar J, Wickramasinghe KK, et al. Evaluation of research on interventions aligned to WHO ‘Best Buys’ for NCDs in low-income and lower-middle-income countries: a systematic review from 1990 to 2015. BMJ Glob Health. 2018;3:e000535.
- World Health Organization. World Health Organization, Geneva. Scaling up action against noncommunicable diseases: how much will it cost? 2011; ISBN 978 92 4 150231 3. [cited 2018 Oct 19]. Available from: https://apps.who.int/iris/bitstream/handle/10665/44706/9789241502313_eng.pdf;jsessionid=8A3E4CE37E53BBB1444D4E9E18FC2D32?sequence=1
- Arredondo A, Zuniga A. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico. Am J Hypertens. 2006;19:553–559.
- Decimoni TC, Leandro R, Rozman LM, et al. Systematic review of health economic evaluation studies developed in Brazil from 1980 to 2013. Front Public Health. 2018;6:52.
- McDaid D, Park AL. Evidence on financing and budgeting mechanisms to support intersectoral actions between health, education, social welfare and labour sectors. Copenhagen, Denmark: World Health Organisation Health Evidence Network Synthesis Reports; 2016.
- Manninen T, Waller M. Finnish municipalities obliged to improve preventive mental health services for the young. Ministry Of Social Affairs and Health, Finland. 2010; [cited 2018 Jun 22]. Available from: https://stm.fi/en/article/-/asset_publisher/finnishmunicipalities-obliged-to-improve-preventive-mental-health-serv-ices-for-the-young
- Government of Canada. Public Health Agency of Canada's Innovation Strategy. 2017; [cited 2018 Jun 22]. Available from: https://www.canada.ca/en/public-health/services/innovation-strategy.html
- Workplace health management - Health Promotion Switzerland. Workplace health management (WHM), Switzerland. 2016; [cited 2018 Jun 29]. Available from: https://healthpromotion.ch/economy.html
- Thai Health Promotion Foundation, Thailand. TRI-POWER STRATEGY. 2001; [cited 2018 Jun 22]. Available from: http://en.thaihealth.or.th/WHO_WE_ARE/THAIHEALTH_PLANS/
- Campolina AG, Yuba TY, Decimoni TC, et al. Health economic evaluations of cancer in Brazil: a systematic review. Front Public Health. 2018;6:205.
- Rantala R, Bortz M, Armada F. Intersectoral action: local governments promoting health. Health Promotion Int. 2014;29:i92–i102.
- Sándor J, Kósa K, Papp M, et al. Capitation-based financing hampers the provision of preventive services in primary health care. Front Public Health. 2016;4:200; https://doi.org/10.3389/fpubh.2016.00200
- Preker AS, Carrin G, Dror D, et al. 2002. Effectiveness of community health financing in meeting the cost of illness. Bulletin of the World Health Organization. 2002;80:143–150.
- Milstein R, Schreyoegg J. Pay for performance in the inpatient sector: A review of 34 P4P programs in 14 OECD countries. Health Policy. 2016;120:1125–1140.
- Jakab M, Krishnan C. Review of the strengths and weaknesses of community financing. Health Financ Poor People. 2004;54–117.
- Arredondo A. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Medicine. 2014;12:136.
- General Assembly, United Nations. Transforming our world: the 2030 Agenda for Sustainable Development, 2015; [cited 2018 Jun 29]. Available from: https://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E
- World Health Organization, Geneva. NCD Global Monitoring Framework, 2013. [cited 2018 Jun 28]. Available from: https://www.who.int/nmh/global_monitoring_framework/2013-11-06-who-dc-c268-whp-gap-ncds-techdoc-def3.pdf?ua=1
- World Health Organization, Geneva. Global Action Plan for the Prevention and Control of NCDs 2013–2020, 2013. [cited 2018 Jun 28]. Available from: https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf;jsessionid=AEACE1006F719E31700889BA17CA90A1?sequence=1
- Nugent R, Feigl A. Where have all the donors gone? Scarce donor funding for non-communicable diseases. 2010; https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1824392
- Dieleman JL, Graves CM, Templin T, et al. Global health development assistance remained steady in 2013 but did not align with recipients' disease burden. Health Aff. 2014;33:878–886.
- Stuckler D, Basu S, McKee M. Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? BMJ. 2011;343:d5336.
- Sridhar D, Batniji R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008;372:1185–1191.
- Bloom DE, Cafiero E, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. PGDA Working Papers 8712, Program on the Global Demography of Aging. 2012.
- Kankeu HT, Saksena P, Xu K, et al. The financial burden from non-communicable diseases in low-and middle-income countries: a literature review. Health Res Policy Sy. 2013;11:31.
- Probst-Hensch N, Tanner M, Kessler C, et al. Prevention: a cost-effective way to fight non-communicable disease epidemic. Swiss Med Wkly. 2011;141:w13266.